FI102754B1 - Menetelmä terapeuttisesti käyttökelpoisten pyridatsino[4,5-b]kinoliinien tai niiden alkyyli- tai asyylijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten pyridatsino[4,5-b]kinoliinien tai niiden alkyyli- tai asyylijohdannaisten valmistamiseksiInfo
- Publication number
- FI102754B1 FI102754B1 FI922099A FI922099A FI102754B1 FI 102754 B1 FI102754 B1 FI 102754B1 FI 922099 A FI922099 A FI 922099A FI 922099 A FI922099 A FI 922099A FI 102754 B1 FI102754 B1 FI 102754B1
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- opt
- substd
- phenyl
- ring
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 title abstract 12
- 125000002252 acyl group Chemical group 0.000 title 1
- BWGUQNLLOGKYEI-UHFFFAOYSA-N pyridazino[4,5-b]quinoline Chemical compound C1=NN=CC2=CC3=CC=CC=C3N=C21 BWGUQNLLOGKYEI-UHFFFAOYSA-N 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- BOYBQQBDCOIBIR-UHFFFAOYSA-N pyrido[2,3-f]cinnoline Chemical compound N1=CC=C2C3=NC=CC=C3C=CC2=N1 BOYBQQBDCOIBIR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9109973 | 1991-05-09 | ||
| GB919109973A GB9109973D0 (en) | 1991-05-09 | 1991-05-09 | Therapeutic compositions |
| GB9202991 | 1992-02-13 | ||
| GB929202991A GB9202991D0 (en) | 1992-02-13 | 1992-02-13 | Compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI922099A0 FI922099A0 (fi) | 1992-05-08 |
| FI922099A FI922099A (fi) | 1992-11-10 |
| FI102754B1 true FI102754B1 (fi) | 1999-02-15 |
| FI102754B FI102754B (fi) | 1999-02-15 |
Family
ID=26298868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI922099A FI102754B (fi) | 1991-05-09 | 1992-05-08 | Menetelmä terapeuttisesti käyttökelpoisten pyridatsino£4,5-b|kinoliini en tai niiden alkyyli- tai asyylijohdannaisten valmistamiseksi |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US5604227A (de) |
| EP (1) | EP0516297B1 (de) |
| JP (1) | JP3279633B2 (de) |
| KR (1) | KR100231095B1 (de) |
| AT (1) | ATE144707T1 (de) |
| AU (1) | AU642086B2 (de) |
| CA (1) | CA2067537A1 (de) |
| CZ (1) | CZ286814B6 (de) |
| DE (1) | DE69214881T2 (de) |
| DK (1) | DK0516297T3 (de) |
| ES (1) | ES2093782T3 (de) |
| FI (1) | FI102754B (de) |
| GB (1) | GB9208511D0 (de) |
| GR (1) | GR3021512T3 (de) |
| HU (2) | HUT61302A (de) |
| IE (1) | IE921294A1 (de) |
| IL (1) | IL101711A0 (de) |
| MY (1) | MY108482A (de) |
| NO (1) | NO180619C (de) |
| NZ (1) | NZ242540A (de) |
| SK (1) | SK280336B6 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2676053B1 (fr) * | 1991-05-03 | 1993-08-27 | Sanofi Elf | Nouveaux composes dialkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| GB9208511D0 (en) * | 1991-05-09 | 1992-06-03 | Ici Plc | Compounds |
| CA2115792C (en) | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
| US5834479A (en) * | 1993-03-05 | 1998-11-10 | Mayer; David J. | Method and composition for alleviating pain |
| GB9420590D0 (en) * | 1993-10-22 | 1994-11-30 | Zeneca Ltd | Pyridazino quinoline compounds |
| GB9411955D0 (en) * | 1994-06-15 | 1994-08-03 | Merck Sharp & Dohme | Therapeutic agents |
| US6214826B1 (en) | 1994-11-12 | 2001-04-10 | Zeneca Limited | Pyridazino quinoline compounds |
| GB9422894D0 (en) * | 1994-11-12 | 1995-01-04 | Zeneca Ltd | Pyridazino quinoline compounds |
| GB9507318D0 (en) * | 1995-04-07 | 1995-05-31 | Zeneca Ltd | Alpha substituted pyridazino quinoline compounds |
| US5776935A (en) * | 1996-07-25 | 1998-07-07 | Merz & Co. Gmbh & Co. | Pyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmission |
| US6861442B1 (en) * | 1998-12-30 | 2005-03-01 | Sugen, Inc. | PYK2 and inflammation |
| EA200100921A1 (ru) * | 1999-03-31 | 2002-04-25 | Басф Акциенгезельшафт | Диамиды пиридин-2,3-дикарбоновой кислоты |
| US6417394B2 (en) * | 2000-04-05 | 2002-07-09 | Bristol Myers Squibb Pharma Company | Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators |
| KR100965861B1 (ko) | 2002-10-24 | 2010-06-24 | 삼성전자주식회사 | 이동통신 시스템에서 복합 재전송 제어 장치 |
| GB0525068D0 (en) * | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9208511D0 (en) * | 1991-05-09 | 1992-06-03 | Ici Plc | Compounds |
-
1992
- 1992-04-16 GB GB929208511A patent/GB9208511D0/en active Pending
- 1992-04-22 IE IE129492A patent/IE921294A1/en not_active IP Right Cessation
- 1992-04-28 MY MYPI92000780A patent/MY108482A/en unknown
- 1992-04-28 AU AU15213/92A patent/AU642086B2/en not_active Ceased
- 1992-04-28 IL IL101711A patent/IL101711A0/xx unknown
- 1992-04-29 NZ NZ242540A patent/NZ242540A/en unknown
- 1992-04-29 CA CA002067537A patent/CA2067537A1/en not_active Abandoned
- 1992-05-04 HU HU9201486A patent/HUT61302A/hu unknown
- 1992-05-06 DK DK92304084.4T patent/DK0516297T3/da active
- 1992-05-06 AT AT92304084T patent/ATE144707T1/de not_active IP Right Cessation
- 1992-05-06 ES ES92304084T patent/ES2093782T3/es not_active Expired - Lifetime
- 1992-05-06 DE DE69214881T patent/DE69214881T2/de not_active Expired - Fee Related
- 1992-05-06 EP EP92304084A patent/EP0516297B1/de not_active Expired - Lifetime
- 1992-05-07 CZ CS19921396A patent/CZ286814B6/cs not_active IP Right Cessation
- 1992-05-07 SK SK1396-92A patent/SK280336B6/sk unknown
- 1992-05-08 NO NO921841A patent/NO180619C/no not_active IP Right Cessation
- 1992-05-08 KR KR1019920007938A patent/KR100231095B1/ko not_active IP Right Cessation
- 1992-05-08 FI FI922099A patent/FI102754B/fi active
- 1992-05-11 JP JP11728592A patent/JP3279633B2/ja not_active Expired - Fee Related
-
1995
- 1995-04-13 US US08/421,133 patent/US5604227A/en not_active Expired - Lifetime
- 1995-04-24 US US08/427,469 patent/US5599814A/en not_active Expired - Lifetime
- 1995-06-23 HU HU95P/P00416P patent/HU211149A9/hu unknown
-
1996
- 1996-08-05 US US08/689,259 patent/US5733910A/en not_active Expired - Lifetime
- 1996-08-15 US US08/700,654 patent/US5739133A/en not_active Expired - Fee Related
- 1996-10-31 GR GR960402628T patent/GR3021512T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI102754B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyridatsino[4,5-b]kinoliinien tai niiden alkyyli- tai asyylijohdannaisten valmistamiseksi | |
| ES482087A1 (es) | Un procedimiento para la preparacion de un compuesto. | |
| TW229156B (de) | ||
| JPS57176988A (en) | Penam-3-carboxylic acid derivative and its preparation | |
| JPS5798288A (en) | Novel cephem compound or its salt, their preparation, and preventive and remedy for bacteriosis containing said compound as active component | |
| IE33535B1 (en) | New penicillins | |
| JPS5466686A (en) | Quinoline-3-carboxylic acid derivative, its preparation, and pharmaceutical composition containig the same | |
| SE8008540L (sv) | N-substituerade tiazolylderivat av oxi-imino-substituerade cefalosporiner och forfarande for framstellning derav | |
| JPS57203067A (en) | Novel quinolinecarboxylic acid derivatives, their preparations, and antibacterial agent comprising them as active ingredient | |
| ES8105007A1 (es) | Un procedimiento para la preparacion de nuevos compuestos amidicos de penicilina | |
| Edwards et al. | . beta.-Lactam antibiotics derived from nitrogen hetrocyclic acetic acids. 1. Penicillin derivatives | |
| EP0675127A4 (de) | Chinolincarbonsäurederivate und verfahren zu ihrer herstellung. | |
| JPS57156495A (en) | Cephalosporin derivative and remedy for microbism used in oral administration | |
| ES8604556A1 (es) | Procedimiento para preparar derivados de flaveno y tioflave-no | |
| SE8009049L (sv) | 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar | |
| ES8503655A1 (es) | Un procedimiento para preparar nuevas dihidropiridinas. | |
| JPS5770889A (en) | 1-ethyl-1,8-naphthyridine derivative and salt thereof | |
| JPS57136586A (en) | Cephalosporin derivative and its preparation | |
| JPS6425783A (en) | Novel cephalosporin compound and antibacterial material | |
| FR2456099A1 (fr) | Derives de 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)-pyrimidin-4-one, procede pour leur preparation et application a titre de medicament | |
| JPS572219A (en) | Oral remedy for infectious disease | |
| ES8403135A1 (es) | Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico. | |
| JPS6466191A (en) | Novel cephalosporin derivative and antibacterial | |
| JPS5466693A (en) | Cephalosporin derivative and its preparation | |
| PT83735A (en) | Process for the preparation of thiazolo]4,5-c" quinoline derivatives |